Eloxx Pharmaceuticals, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Arlington, MA
ELOX chart
What traders are saying about $ELOX
Latest postsEloxx Pharmaceuticals, Inc. news
- Eloxx Pharmaceuticals Stock Price Forecast. Should You Buy ELOX?
StockInvest.us ·
- Cystic Fibrosis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 75+ Leading Players Wheeling the Therapeutics Landscape
StreetInsider ·
- Eloxx Pharmaceuticals, Inc. Estimates – NASDAQ:ELOX
TradingView ·
- Form 4 Eloxx Pharmaceuticals Inc: Geno J. Germano (Director) For: 19 October
Investing.com Australia ·
- Director Geno J. Germano receives Eloxx Pharmaceuticals (ELOX) options with a $12.50 exercise price.
Stock Titan ·
- Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D., Chief Medical Officer
Yahoo Finance ·
- Eloxx Pharmaceuticals Appoints Biopharmaceutical Industry Veteran Geno Germano to its Board of Directors
Yahoo Finance ·
- Eloxx Pharmaceuticals Announces First Patients Dosed in Phase 2b EXACT Study of Exaluren in Nonsense Mutation Alport Syndrome
Yahoo Finance ·
- Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
Yahoo Finance ·
Eloxx Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $6.4M | $0 | – |
| Net income | -$6.0M | -$3.1M | -$17.1M | -$36.1M |
| Diluted EPS | $-5.34 | $-9.20 | $-72.98 | $-16.65 |
| Total assets (year end) | $5.3M | $3.0M | $1.7M | $21.1M |
| Cash and equivalents (year end) | $4.8M | $111,000 | $1.1M | $19.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Eloxx Pharmaceuticals, Inc.
- Ticker
- ELOX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Arlington, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1035354
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
Frequently asked questions
What exchange is Eloxx Pharmaceuticals, Inc. listed on?
Eloxx Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol ELOX.
What industry is Eloxx Pharmaceuticals, Inc. in?
Eloxx Pharmaceuticals, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Eloxx Pharmaceuticals, Inc. headquartered?
Eloxx Pharmaceuticals, Inc.'s business address on file with the SEC is in Arlington, MA.
When does Eloxx Pharmaceuticals, Inc.'s fiscal year end?
Eloxx Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Eloxx Pharmaceuticals, Inc. report?
Eloxx Pharmaceuticals, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.